Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

PFE

Pfizer Inc

Oct 27 • 04:00PM ET

24.77

+0.01 0.04 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: BMY MRK SNY AMGN ABBV NVS JNJ GSK LLY AZN

| Held by: VTI VOO IVV SPY VTV XLV VYM VHT DVY FDL

Index	S&P 500	P/E	13.18	EPS (ttm)	1.88	Insider Own	0.11%	Shs Outstand	5.68B	Perf Week	0.32%
Market Cap	140.83B	Forward P/E	7.90	EPS next Y	3.14	Insider Trans	0.00%	Shs Float	5.68B	Perf Month	4.25%
Enterprise Value	189.70B	PEG	-	EPS next Q	0.64	Inst Own	66.81%	Short Float	2.06%	Perf Quarter	1.93%
Income	10.73B	P/S	2.21	EPS this Y	-2.10%	Inst Trans	-0.51%	Short Ratio	2.38	Perf Half Y	7.46%
Sales	63.83B	P/B	1.59	EPS next Y	3.04%	ROA	5.08%	Short Interest	116.82M	Perf YTD	-6.63%
Book/sh	15.60	P/C	10.63	EPS next 5Y	-0.22%	ROE	12.16%	52W High	29.17 -15.08%	Perf Year	-14.17%
Cash/sh	2.33	P/FCF	11.32	EPS past 3/5Y	-28.69% -13.27%	ROIC	7.34%	52W Low	20.92 18.43%	Perf 3Y	-42.27%
Dividend Est.	1.70 (6.87%)	EV/EBITDA	7.39	Sales past 3/5Y	-7.84% 9.10%	Gross Margin	67.34%	Volatility	1.02% 2.32%	Perf 5Y	-30.28%
Dividend TTM	1.71 (6.90%)	EV/Sales	2.97	EPS Y/Y TTM	510.84%	Oper. Margin	29.60%	ATR (14)	0.45	Perf 10Y	-24.24%
Dividend Ex-Date	Nov 07, 2025	Quick Ratio	0.85	Sales Y/Y TTM	14.72%	Profit Margin	16.81%	RSI (14)	48.51	Recom	2.48
Dividend Gr. 3/5Y	2.49% 2.97%	Current Ratio	1.16	EPS Q/Q	11938.10%	SMA20	-2.17%	Beta	0.51	Target Price	28.74
Payout	120.11%	Debt/Eq	0.70	Sales Q/Q	10.31%	SMA50	-0.41%	Rel Volume	0.71	Prev Close	24.76
Employees	81000	LT Debt/Eq	0.65	Earnings	Nov 04 BMO	SMA200	0.23%	Avg Volume	49.00M	Price	24.77
IPO	Jan 17, 1944	Option/Short	Yes / Yes	EPS/Sales Surpr.	34.39% 8.06%	Trades		Volume	34,752,961	Change	0.04%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$24
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43
Feb-07-23	Upgrade	Daiwa Securities	Neutral → Outperform	$51
Jan-26-23	Downgrade	UBS	Buy → Neutral	$55 → $47
Jan-17-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$54 → $50
Jan-04-23	Downgrade	BofA Securities	Buy → Neutral	$60

Show Previous Ratings

Today 02:00PM	3 Dividend-Paying Drug Stocks to Buy at a Discount (Motley Fool)
12:21PM	What Is 1 of the Best Pharmaceutical Stocks to Buy Now? (Motley Fool)
12:15PM	Should You Buy Pfizer Stock Before Nov. 4? (Motley Fool)
09:17AM	Should You Buy, Hold, or Sell BMY Stock Ahead of Q3 Earnings? (Zacks)
08:30AM	Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology (PR Newswire)
08:00AM	Loading…
08:00AM	2 Unstoppable Health Care Giants to Buy Right Now for Less Than $1,000 (Motley Fool)
05:43AM	Prediction: Vertex Pharmaceuticals Will Be Worth More Than Pfizer by 2030 (Motley Fool)
04:30AM	3 Healthcare Stocks Paying the Highest Dividends of 2025 (Motley Fool)
04:00AM	Mercks oncology prospects could portend a post-Keytruda future (Pharma Voice)
Oct-26-25 10:19AM	More Rate Cuts Are Coming: Grab 6% High-Yield S&P 500 Stocks Now (24/7 Wall St.)
07:25AM	Pfizer Inc. (PFE) and Astellas Pharma Announce Survival Results from Phase 3 EMBARK Study (Insider Monkey)
04:00AM	Got $1,000? 3 High-Yield Healthcare Stocks to Buy and Hold Forever. (Motley Fool)
Oct-25-25 07:00AM	2 Unstoppable Dividend Stocks Yielding More Than 4% That Income-Seeking Investors Will Want to Buy in November and Hold Forever (Motley Fool)
Oct-24-25 04:12PM	Sanofi Jumps As Dupixent Nears $5 Billion In Sales; Trump Drug Talks Continue (Investor's Business Daily)
12:07PM	A GSK Cancer Drug Is Making a Comeback. It's So-So News for the Stock. (Barrons.com)
11:30AM	Loading…
11:30AM	PFE versus BMY: Which Large Oncology Drugmaker Is a Better Pick Now? (Zacks)
09:29AM	Here's How Eli Lilly's Oncology Drugs Are Poised Ahead of Q3 Earnings (Zacks)
09:00AM	Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
04:45AM	Sanofi Earnings Get Boost From Dupixent, New Drugs as U.S. Talks Continue (The Wall Street Journal)
Oct-23-25 06:51PM	Dividend Stocks Arent Just for Income Investors. Heres Another Reason to Buy Them. (Barrons.com)
12:53PM	Roche in ongoing discussions with US government over drug pricing, CEO says (Pharmaceutical Technology)
11:15AM	Medpace Holdings' Good Quarter Is Another Sign Biotech Is Back (Barrons.com)
10:39AM	Lilly Up 10% in a Month: Should You Buy, Sell or Hold the Stock? (Zacks)
08:09AM	The Other Reason to Buy Dividend Stocks (Barrons.com)
05:24AM	Roche Raises Full-Year Earnings Outlook as U.S. Drug-Pricing Talks Continue (The Wall Street Journal)
03:30AM	The Other Reason to Buy Dividend Funds (Barrons.com)
Oct-22-25 10:29AM	AbbVie Up More Than 30% in 6 Months: How to Play the Stock (Zacks)
06:27AM	Thermo Scientific Revenue Rises, Boosted by Life Sciences Business (The Wall Street Journal)
Oct-21-25 01:35PM	Danaher Third-Quarter Earnings Rise; Pharma R&D Spend Expected to Rebound (The Wall Street Journal)
08:58AM	Will BMY's Growth Portfolio Drive Third-Quarter Results? (Zacks)
07:37AM	Loading…
07:37AM	2 Mega-Dividend Stocks With Yields As High As 7% (Motley Fool)
06:23AM	Danaher Sales and Profit Rise on Bioprocessing Momentum (The Wall Street Journal)
05:52AM	Pfizer Inc. (PFE) Announces Positive Results From its Phase 3 HER2CLIMB-05 Trial (Insider Monkey)
Oct-20-25 02:03PM	Elon Musk takes shot at rival facing major problem (TheStreet)
10:15AM	Pfizer's Q3 Non-Oncology Performance: Here's What to Expect (Zacks)
10:10AM	How Will DefenCath Aid CRMD's Top Line in the Upcoming Q3 Results? (Zacks)
10:10AM	Here's What to Expect From AbbVie's Oncology Segment in Q3 Earnings (Zacks)
Oct-19-25 10:57AM	2 High-Yield Dividend Stocks Too Cheap to Ignore (Motley Fool)
04:15AM	XTANDI Plus Leuprolide Reduced Risk of Death by 40% vs Leuprolide Alone in Men with a Type of Advanced Prostate Cancer (Business Wire)
02:30AM	Pfizer's BRAFTOVI + MEKTOVI Shows Sustained Long-Term Survival in Patients with Advanced Lung Cancer (Business Wire)
Oct-18-25 10:35AM	Pfizer, Merck And Astellas Have An 'Enormous New Hope' For Bladder Cancer Patients (Investor's Business Daily)
10:30AM	PADCEV Plus KEYTRUDA, Given Before and After Surgery, Cuts the Risk of Recurrence, Progression or Death by 60% and the Risk of Death by 50% for Certain Patients with Bladder Cancer (PR Newswire)
Oct-17-25 06:42PM	Top Analyst Reports for Home Depot, Boeing & Progressive (Zacks)
05:45PM	Pfizer (PFE) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
02:02PM	Biotech Is Finally Rallying. Why Mizuhos Jared Holz Is Optimistic This Time. (Barrons.com)
12:11PM	Should You Buy, Sell or Hold J&J Stock After Robust Q3 Earnings? (Zacks)
09:00AM	Precision Oncology Approaches Drive $312B Market Transformation (PR Newswire)
03:31AM	Novo, Lilly Fall as Trump Touts Much Lower Ozempic Price (Bloomberg)
Oct-16-25 05:09PM	Trump: Cost of Ozempic Could Be $150. Dr. Oz: Not Yet. (The Wall Street Journal)
05:02PM	Trump Strikes Deal With German Merck on Tariffs, IVF Costs (Bloomberg)
10:45AM	Pfizer Strikes $70B Deal with Trump--But Warns China Is Racing Ahead in Biotech War (GuruFocus.com)
09:00AM	Inside Yahoo Finance Invest 2025: AI stock bubble, Trump tariff realities, a Fed under siege, and another crypto boom (Yahoo Finance)
08:12AM	A Once-in-a-Decade Investment Opportunity: 1 Pharmaceutical Stock to Buy Now Hand Over Fist and Hold for Years (Motley Fool)
06:17AM	Pfizers Q3 2025 Earnings: What to Expect (Barchart)
Oct-15-25 08:40AM	Pharma M&A Activity Picks Up Pace: What Does It Signal for 2026? (Zacks)
07:40AM	Pfizer touts Tukysa in front-line breast cancer after Phase III victory (Pharmaceutical Technology)
Oct-14-25 05:10PM	Health Care Roundup: Market Talk (The Wall Street Journal)
01:33PM	Top Novavax Shareholder Demands Company's Sale (Barrons.com)
10:38AM	CorMedix Stock Plunges 16% in a Month: Should Investors Buy the Dip? (Zacks)
10:01AM	BMY Slips Below 50-Day SMA: Buy, Sell or Hold the Stock? (Zacks)
08:43AM	Johnson & Johnson Earnings Beat Estimates. Why the Stock Is Dropping. (Barrons.com)
06:45AM	TUKYSA Combination Significantly Improves Progression-Free Survival as First-Line Maintenance in HER2+ Metastatic Breast Cancer in HER2CLIMB-05 Trial (Business Wire)
06:20AM	Johnson & Johnson Says It Will Spin Off Orthopaedics Business (Barrons.com)
Oct-13-25 11:16PM	Pfizer's (PFE) Pipeline and Dividend Yield Make it a Compelling Income Stock (Insider Monkey)
05:04PM	This Pharma Play, The IBD Stock Of The Day, Is Offering Another Entry Amid 100% Advance This Year (Investor's Business Daily)
03:24PM	Trump's AstraZeneca Deal Echoes Pfizer Pact. Big Pharma's Political Headaches Are Easing. (Barrons.com)
02:50PM	Protagonist Therapeutics Stock Gains 30% as J&J Reportedly Eyes Deal (Zacks)
01:40PM	AZN Strikes Drug Pricing Deal With Trump, Gets 3-Year Tariff Reprieve (Zacks)
10:57AM	New US biotech hubs showing potential amid onshoring request (Pharmaceutical Technology)
10:36AM	Analyst Report: Zoetis Inc. (Morningstar Research)
09:00AM	Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know (Zacks)
08:45AM	Where Will Pfizer Be in 5 Years? (Motley Fool)
06:45AM	Pfizer to Highlight Advancements in Respiratory Health and Infectious Disease Research at IDWeek 2025 (Business Wire)
06:10AM	Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest? (Motley Fool)
05:30AM	Why Biotech's Rally Can Last This Time (The Wall Street Journal)
Oct-12-25 02:28PM	4 Dividend Stocks to Double Up on Right Now -- Including United Parcel Service and Pfizer (Motley Fool)
Oct-11-25 07:00AM	MarketBeat Week in Review - 10/06 - 10/10 (MarketBeat)
Oct-10-25 08:27PM	AstraZeneca Cuts Discounted Drug Pricing Deal With the White House. The Stock Is Rising. (Barrons.com)
08:18PM	Biotech Stocks Have Struggled Since 2021. Why They're Coming Back. (Barrons.com)
07:11PM	AstraZeneca Strikes Drug-Pricing Deal With Trump Administration (The Wall Street Journal)
06:39PM	Trump reaches deal with AstraZeneca to lower U.S. drug prices (CNBC TV)
06:09PM	AstraZeneca becomes latest drugmaker to strike deal with Trump. Its stock is climbing after hours. (MarketWatch)
05:58PM	Trump Announces AstraZeneca Drug Price Cuts for Tariff Reprieve (Bloomberg)
04:38PM	AstraZeneca to Ink Drug-Pricing Deal With Trump Administration (The Wall Street Journal)
12:19PM	Bristol Myers Squibb Buys Private Biotech for $1.5 Billion. The Deal Wave Keeps Going. (Barrons.com)
06:45AM	2 Pharmaceutical Stocks That Look Like No-Brainer Buys Right Now (Motley Fool)
05:32AM	Pharma R&D set to endure despite rising MFN costs (Clinical Trials Arena)
03:18AM	Here's How This Pharmaceutical Giant Is Protecting Itself From President Trump's Tariffs. Should It Matter to Investors? (Motley Fool)
Oct-09-25 05:45PM	Here's Why Pfizer (PFE) Fell More Than Broader Market (Zacks)
04:30PM	Pfizer Declares Fourth-Quarter 2025 Dividend (Business Wire)
03:26PM	A Major Eli Lilly Shareholder Has Sold Stock Nearly Every Day in October. Here's Who It Is. (Barrons.com)
08:03AM	5 Healthcare Plays Powering the Sector's Big Comeback (MarketBeat)
Oct-08-25 04:19PM	Here Are the 12 Best Buyback Aristocrat Stocks (Barrons.com)
04:19PM	Here Are the 12 Best 'Buyback Aristocrats' (Barrons.com)
02:48PM	Finally, Tariffs the Stock Market Likes. Why Pharma Levies May Do the Trick. (Barrons.com)
11:28AM	Should You Buy Pfizer (PFE) Before a Breakout Begins? (Insider Monkey)
08:50AM	Here's What to Expect From Pfizer's Oncology Drugs in Q3 Earnings (Zacks)
08:42AM	3 Large Drug Stocks to Watch as Industry Recovers After PFE-Trump Deal (Zacks)
07:16AM	Why AbbVie and Johnson & Johnson Could Outperform Pfizer (MarketBeat)
Oct-07-25 05:04PM	Former Top FDA Official, Forced Out by Kennedy, Lands at Eli Lilly (Barrons.com)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dolsten Mikael	Former Officer	May 23 '25	Proposed Sale	23.09	59,781	1,380,632		May 23 10:54 AM
Dolsten Mikael	Former Officer	May 05 '25	Proposed Sale	23.87	55,000	1,312,736		May 05 04:45 PM
DAMICO JENNIFER B.	SVP & Controller	Mar 04 '25	Sale	25.93	2,500	64,825	11,850	Mar 06 01:57 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 27 '25	Option Exercise	31.31	22,416	701,845	31,063	Mar 03 05:39 PM
SUSMAN SALLY	Executive Vice President	Feb 27 '25	Option Exercise	31.31	85,182	2,667,048	250,866	Mar 03 05:38 PM
SAHNI PAYAL	Executive Vice President	Feb 27 '25	Option Exercise	31.31	19,054	596,581	44,242	Mar 03 05:38 PM
McDermott Michael	Executive Vice President	Feb 27 '25	Option Exercise	31.31	48,419	1,515,999	122,413	Mar 03 05:37 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 27 '25	Option Exercise	31.31	156,914	4,912,977	309,790	Mar 03 05:37 PM
Fonseca Lidia	Executive Vice President	Feb 27 '25	Option Exercise	31.31	72,629	2,274,014	111,534	Mar 03 05:36 PM
BOURLA ALBERT	Chairman & CEO	Feb 27 '25	Option Exercise	31.31	582,823	18,248,188	931,744	Mar 03 05:36 PM
McDermott Michael	Executive Vice President	Feb 22 '25	Option Exercise	30.17	11,125	335,641	87,636	Feb 25 07:38 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 22 '25	Option Exercise	30.17	8,741	263,716	17,602	Feb 25 07:38 PM
BOURLA ALBERT	Chairman & CEO	Feb 22 '25	Option Exercise	30.17	238,399	7,192,498	570,436	Feb 25 07:06 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 22 '25	Option Exercise	30.17	85,824	2,589,310	232,775	Feb 25 07:05 PM
SAHNI PAYAL	Executive Vice President	Feb 22 '25	Option Exercise	30.17	12,714	383,581	37,099	Feb 25 07:04 PM
SUSMAN SALLY	Executive Vice President	Feb 22 '25	Option Exercise	30.17	63,573	1,917,997	225,184	Feb 25 07:02 PM
BOSHOFF CHRISTOFFEL	President, R&D	Feb 22 '25	Option Exercise	30.17	8,741	263,716	159,085	Feb 25 06:58 PM
BLAYLOCK RONALD E	Director	Feb 13 '25	Buy	25.65	19,457	499,072	27,707	Feb 14 05:16 PM
Gottlieb Scott	Director	Oct 30 '24	Buy	28.24	1,000	28,240	10,000	Oct 31 04:06 PM

Open in Screener

KMX

Carmax Inc

Oct 27 • 04:00PM ET

45.08

+0.82 1.85 %

Consumer Cyclical • Auto & Truck Dealerships • USA • NYSE

Peers: AN LAD PAG SAH ABG GPI TSLA GM F HOG

| Held by: VTI VOO VB RSP VBR IVV SPY XLY IWR EQTY

Index	S&P 500	P/E	13.24	EPS (ttm)	3.40	Insider Own	0.52%	Shs Outstand	147.67M	Perf Week	4.76%
Market Cap	6.62B	Forward P/E	11.97	EPS next Y	3.77	Insider Trans	1.50%	Shs Float	145.97M	Perf Month	0.49%
Enterprise Value	24.80B	PEG	-	EPS next Q	0.69	Inst Own	109.45%	Short Float	9.91%	Perf Quarter	-23.68%
Income	521.07M	P/S	0.23	EPS this Y	0.91%	Inst Trans	-1.34%	Short Ratio	3.85	Perf Half Y	-30.76%
Sales	28.28B	P/B	1.07	EPS next Y	16.24%	ROA	1.92%	Short Interest	14.47M	Perf YTD	-44.86%
Book/sh	41.99	P/C	5.71	EPS next 5Y	-	ROE	8.42%	52W High	91.25 -50.60%	Perf Year	-37.39%
Cash/sh	7.89	P/FCF	9.66	EPS past 3/5Y	-22.80% -9.64%	ROIC	2.11%	52W Low	42.34 6.47%	Perf 3Y	-20.17%
Dividend Est.	-	EV/EBITDA	21.66	Sales past 3/5Y	-5.28% 5.66%	Gross Margin	11.52%	Volatility	3.16% 3.08%	Perf 5Y	-50.53%
Dividend TTM	-	EV/Sales	0.88	EPS Y/Y TTM	28.59%	Oper. Margin	2.87%	ATR (14)	1.66	Perf 10Y	-20.70%
Dividend Ex-Date	-	Quick Ratio	1.06	Sales Y/Y TTM	2.17%	Profit Margin	1.84%	RSI (14)	41.79	Recom	2.45
Dividend Gr. 3/5Y	- -	Current Ratio	2.46	EPS Q/Q	-24.88%	SMA20	1.41%	Beta	1.27	Target Price	50.83
Payout	0.00%	Debt/Eq	3.12	Sales Q/Q	-5.26%	SMA50	-14.59%	Rel Volume	0.86	Prev Close	44.26
Employees	30048	LT Debt/Eq	2.98	Earnings	Sep 25 BMO	SMA200	-31.92%	Avg Volume	3.76M	Price	45.08
IPO	Feb 04, 1997	Option/Short	Yes / Yes	EPS/Sales Surpr.	-38.67% -5.88%	Trades		Volume	3,231,542	Change	1.85%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-07-25	Downgrade	Stephens	Overweight → Equal-Weight	$42
Sep-29-25	Downgrade	Seaport Research Partners	Buy → Neutral
Sep-26-25	Downgrade	Oppenheimer	Outperform → Perform
Sep-26-25	Downgrade	Evercore ISI	Outperform → In-line	$52
Sep-25-25	Downgrade	Wedbush	Outperform → Neutral
Aug-06-25	Upgrade	JP Morgan	Underweight → Neutral	$58
Jul-17-25	Initiated	The Benchmark Company	Buy	$75
Jul-01-25	Resumed	Morgan Stanley	Overweight	$80
May-19-25	Resumed	Wedbush	Outperform	$90
Mar-26-25	Upgrade	Stephens	Equal-Weight → Overweight	$86 → $90
Feb-06-25	Upgrade	Evercore ISI	In-line → Outperform	$90 → $110
Dec-05-24	Initiated	Stephens	Equal-Weight	$86
Mar-20-24	Upgrade	Needham	Hold → Buy	$99
Mar-19-24	Initiated	Mizuho	Neutral	$80
Sep-25-23	Upgrade	Wedbush	Neutral → Outperform	$85 → $90
Jun-12-23	Downgrade	Northcoast	Buy → Neutral
Feb-23-23	Resumed	Truist	Hold	$66
Jan-11-23	Downgrade	JP Morgan	Neutral → Underweight	$60
Jan-05-23	Downgrade	Argus	Buy → Hold
Dec-23-22	Reiterated	Oppenheimer	Outperform	$100 → $75

Show Previous Ratings

Today 06:10PM	Solstice Advance Materials and Qnity Electronics Set to Join S&P 500; Others to Join S&P SmallCap 600 (PR Newswire)
06:05PM	The S&P 500 Adds 2 Spinoffs to the Index. Here's Who Is Leaving. (Barrons.com)
06:06PM	CarMax to leave the S&P 500 to give way to this famous industrial company's spinoff (MarketWatch)
Oct-19-25 03:08AM	CarMax Faces Omni-Channel Uncertainty as Morgan Stanley Cuts Target (Insider Monkey)
Oct-16-25 08:33AM	Does CarMax (KMX) Still Have Pandemic Strain? (Insider Monkey)
12:01AM	Loading…
12:01AM	CarMax (KMX): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
Oct-15-25 12:38AM	3 Low-Volatility Stocks We Keep Off Our Radar (StockStory)
Oct-14-25 03:34PM	CarMax, Inc. (KMX) Faces Investor Scrutiny After Unexpected $142 Million Loss Provision Sends Shares Tumbling -- Hagens Berman (PR Newswire)
Oct-08-25 04:00PM	Why CarMax Plunged in September (Motley Fool)
09:13AM	These Were the 5 Worst-Performing Stocks in the S&P 500 in September 2025 -- and One's Decline Can Be Tied to President Trump (Motley Fool)
Oct-07-25 04:30PM	CarMax, Kohl's, Macy's, Sleep Number, and MarineMax Stocks Trade Down, What You Need To Know (StockStory)
09:50AM	Netflix upgraded, Dollar Tree downgraded: Wall Street's top analyst calls (The Fly)
Oct-03-25 02:59AM	New Strong Sell Stocks for October 3rd (Zacks)
Oct-02-25 05:14PM	CarMax, Inc. (KMX) Faces Investor Scrutiny After Unexpected $142 Million Loss Provision Sends Shares Tumbling -- Hagens Berman (PR Newswire)
01:10PM	Carvana has a 'competitive moat' over CarMax. But don't sleep on CarMax's stock, Morgan Stanley says. (MarketWatch)
11:07AM	Loading…
11:07AM	CarMax leans on AI, tech investments to trim $150M in costs (CIO Dive)
11:00AM	CarMax Q2 Earnings Miss Expectations, Revenues Decline Y/Y (Zacks)
01:30AM	The 5 Most Interesting Analyst Questions From CarMax's Q3 Earnings Call (StockStory)
Sep-29-25 09:46AM	EA downgraded, AppLovin initiated: Wall Street's top analyst calls (The Fly)
02:47AM	Markets Last Week Roundup: CarMax Woes, Intel Soars, Tylenol Pressure (The Wall Street Journal)
01:21AM	Jim Cramer on CarMax: "Their Customers Need Lower Rates" (Insider Monkey)
01:01AM	COST and KMX- Two Consumer Stocks on Divergent Paths (MoneyShow)
Sep-27-25 01:11PM	CarMax Stock Just Tanked. Time to Buy? (Motley Fool)
07:00AM	MarketBeat Week in Review - 09/22 - 09/26 (MarketBeat)
Sep-26-25 05:04PM	Auto & Transport Roundup: Market Talk (The Wall Street Journal)
04:19PM	CarMax Stock Ends the Week With Another Drop (The Wall Street Journal)
10:55AM	Here's Why You Should Retain CarMax Stock in Your Portfolio Now (Zacks)
10:07AM	Carmax: Now is the Time to Load Up On This Used Car Stock (MarketBeat)
09:55AM	Company News for Sep 26, 2025 (Zacks)
09:46AM	CarMax downgraded, Kenvue upgraded: Wall Street's top analyst calls (The Fly)
09:41AM	Loading…
09:41AM	Analysts turning bearish on CarMax after weak quarter (Investing.com)
08:12AM	CarMax Short Sellers Mint $171 Million in One Day From 20% Drop (Bloomberg)
07:00AM	CarMax (KMX) Falls to All-Time Low as Q2 Earnings Disappoint (Insider Monkey)
03:47AM	Heard on the Street Thursday Recap: Intel Wants a Bite From Apple (The Wall Street Journal)
01:30AM	KMX Q3 Deep Dive: Margin Pressures and Demand Headwinds Dominate Management's Focus (StockStory)
Sep-25-25 07:31PM	Review & Preview: Too Much Good News (Barrons.com) -20.07%
06:43PM	CarMax stock crashes after 'challenging' second-quarter earnings (CNBC TV)
05:29PM	Auto Industry Is Flashing a Warning Sign on U.S. Economy (The Wall Street Journal)
05:15PM	Heard on the Street Recap: Intel Wants a Bite From Apple (The Wall Street Journal)
05:01PM	Auto & Transport Roundup: Market Talk (The Wall Street Journal)
04:55PM	S&P 500 Gains & Losses Today: CarMax Stock Skids, Oracle Retreats; Intel Pushes Higher (Investopedia)
04:44PM	Stocks to Watch Recap: Tesla, Oracle, Intel, Costco (The Wall Street Journal)
04:43PM	Carmax shares hit 52-week low after it misses quarterly estimates (CNBC TV)
04:30PM	These Stocks Moved the Most Today: Intel, Oracle, CarMax, IBM, Lithium Americas, Jabil, Freeport, and More (Barrons.com)
04:27PM	CarMax Stock Falls 20% on Earnings. Why Its a Warning for the Auto Sector. (Barrons.com)
04:19PM	U.S. Stocks Fall After GDP Revised Up (The Wall Street Journal)
03:41PM	Stock Market Today: Dow Falls On Slimmer Rate-Cut Odds; These Stocks Weigh On S&P 500 (Live Coverage) (Investor's Business Daily)
03:02PM	CarMax Inc (KMX) Q2 2026 Earnings Call Highlights: Navigating Sales Decline and Strategic ... (GuruFocus.com)
03:00PM	Why CarMax Stock Crashed Today (Motley Fool)
02:08PM	6These Stocks Are Moving the Most Today: Intel, Oracle, CarMax, IBM, Lithium Americas, Jabil, Freeport, and More (Barrons.com)
01:09PM	Stocks to Watch Thursday: Tesla, Oracle, Intel, IBM (The Wall Street Journal)
12:41PM	Why CarMax (KMX) Shares Are Falling Today (StockStory)
12:15PM	U.S. Stocks Slip After GDP Revised Up (The Wall Street Journal)
11:20AM	Top Stock Movers Now: Intel, IBM, Oracle, Lithium Americas, and More (Investopedia)
11:11AM	CarMax Stock Stalls on Q2 Earnings Setback (Schaeffer's Research)
10:54AM	CarMax Profit Plunge Signals More Pain Ahead for Tariff-Strained Auto Sector (The Wall Street Journal)
10:43AM	Wendy's, CarMax, Uranium Energy: Top Analyst Calls (Yahoo Finance Video)
09:52AM	U.S. Stocks Trade Lower (The Wall Street Journal)
09:38AM	Oracle initiated, Ulta Beauty upgraded: Wall Street's top analyst calls (The Fly)
09:30AM	CarMax (KMX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
09:25AM	Starbucks, CoreWeave-OpenAI, CarMax sales: Trending Tickers (Yahoo Finance Video)
08:57AM	CarMax Stock Hits 52-Week Low After Q2 Earnings - Here's Why (Benzinga)
08:00AM	CarMax (KMX) Q2 Earnings and Revenues Lag Estimates (Zacks)
08:00AM	CarMax sees unexpected drop in used-car sales even at lower prices, and the stock dives (MarketWatch)
07:34AM	CarMax (NYSE:KMX) Misses Q3 Revenue Estimates, Stock Drops 11.7% (StockStory)
07:30AM	CarMax shares tumble as second quarter earnings miss expectations (Investing.com)
07:17AM	CarMax Profit Sinks on Weaker Used Car Sales (The Wall Street Journal)
07:09AM	CarMax Stock Falls Sharply on Earnings as Used Car Sales and Prices Decline (Barrons.com)
06:57AM	CarMax: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
06:50AM	CarMax Reports Second Quarter Fiscal Year 2026 Results (Business Wire)
05:41AM	Costco headlines Thursday's earnings slate (MarketWatch)
04:30AM	Stock Market Today: Dow, S&P 500 and Nasdaq struggle to rally after two-day pullback from record highs; lots of Fed speakers due and big batch of data including initial jobless claims on tap; Costco earnings due. (MarketWatch)
03:52AM	Inflation Data, Costco Earnings, Home Sales: Still to Come This Week (The Wall Street Journal)
12:33AM	Wall Street points toward losses in premarket as recent red-hot rally appears to be petering out (Associated Press)
Sep-24-25 07:00PM	Costco earnings, Fedspeak, existing home sales: What to Watch (Yahoo Finance Video)
05:18PM	Review & Preview: The September Rally Hits a Snag (Barrons.com)
10:17AM	What to Expect From CarMax's Next Quarterly Earnings Report (Barchart)
09:35AM	CarMax Earns Top Honors in 2025: Recently Ranked #6 on Fortune's Best Workplaces in Retail and #38 on PEOPLE's Companies That Care List (GlobeNewswire)
03:36AM	Inflation Data, Costco Earnings, Home Sales: Still to Come This Week (The Wall Street Journal)
02:03AM	How Is CarMax's Stock Performance Compared to Other Cyclical Stocks? (Barchart)
Sep-23-25 11:01PM	CarMax (KMX) Reports Q3: Everything You Need To Know Ahead Of Earnings (StockStory)
07:35AM	CarMax Gears Up to Report Q2 Earnings: Here's What to Expect (Zacks)
Sep-22-25 09:15AM	Gear Up for CarMax (KMX) Q2 Earnings: Wall Street Estimates for Key Metrics (Zacks)
Sep-21-25 02:00PM	Here Comes an Inflation Update. Plus Micron, Costco, AutoZone, Firefly, and More Stocks to Watch This Week. (Barrons.com)
05:00AM	What to Expect in Markets This Week: Inflation Data; Fed Speakers; Earnings from Micron, Costco (Investopedia)
05:00AM	There's a New Way to Play Quarterly Earnings With Polymarket's Latest Rollout (Investopedia)
Sep-19-25 07:00PM	Costco earnings, Fedspeak, PCE: What to Watch (Yahoo Finance Video)
Sep-18-25 10:30AM	The Week Ahead: More Housing Data and a GDP Update (Schaeffer's Research)
Sep-09-25 11:32PM	Q2 Rundown: CarMax (NYSE:KMX) Vs Other Vehicle Retailer Stocks (StockStory)
05:20PM	Lands' End (LE) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
Sep-04-25 05:00PM	CarMax Announces Second Quarter Conference Call (Business Wire)
01:14PM	CarMax (KMX) Launches New Brand Positioning, Introduces New "Wanna Drive?" Tagline (Insider Monkey)
08:40AM	America's Car-Mart (CRMT) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
Sep-02-25 12:34AM	1 S&P 500 Stock to Target This Week and 2 That Underwhelm (StockStory)
Aug-28-25 08:10AM	Dick's Sporting Goods (DKS) Tops Q2 Earnings and Revenue Estimates (Zacks)
03:55AM	What Are Hertz and Amazon Up to Right Now? (Motley Fool)
Aug-26-25 01:30PM	Understanding electric vehicle financing and loans (Stacker)
Aug-25-25 08:05AM	CarMax is Shaping the Future of Car Shopping with New "Wanna Drive?" Brand Positioning and Tagline (GlobeNewswire)
06:30AM	CarMax ditches longtime tagline, repositions brand around omnichannel (Marketing Dive)
Aug-21-25 03:45PM	3 Stocks Down Over 30% That Look Like Buys (Motley Fool)

CarMax, Inc. is a holding company, which engages in the retail of used vehicles and wholesale of vehicle auction operators. It operates through the CarMax Sales Operations and CarMax Auto Finance (CAF) segments. The CarMax Sales Operations segment consists of all aspects of its auto merchandising and service operations. The CAF segment pertains to its finance operation, which offers vehicle financing services to customers buying retail vehicles. The company was founded by Richard L. Sharp and William Austin Ligon in 1993 and is headquartered in Richmond, VA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ONeil Mark F	Director	Oct 02 '25	Buy	46.21	10,816	499,807	24,690	Oct 06 04:11 PM
STEENROD MITCHELL D	Director	Oct 02 '25	Buy	45.57	2,000	91,140	38,330	Oct 03 04:09 PM
Daniels Jon G	EVP, CAF	Jul 02 '25	Sale	70.64	1,540	108,786	2,779	Jul 03 04:11 PM
JON DANIELS	Officer	Jul 02 '25	Proposed Sale	70.64	1,540	108,790		Jul 02 04:27 PM
STEENROD MITCHELL D	Director	Apr 24 '25	Buy	65.49	1,300	85,137	33,577	Apr 25 04:08 PM
Tuite Tyler	SVP & Chief Product Officer	Jan 28 '25	Option Exercise	78.61	4,869	382,752	5,096	Jan 30 04:15 PM
Tuite Tyler	SVP & Chief Product Officer	Jan 28 '25	Sale	84.58	4,869	411,820	227	Jan 30 04:15 PM
Tuite Tyler	Officer	Jan 28 '25	Proposed Sale	84.58	4,869	411,809		Jan 28 05:11 PM
Mayor-Mora Enrique N	EVP & CFO	Jan 15 '25	Option Exercise	63.04	5,000	315,200	25,260	Jan 17 04:41 PM
Mayor-Mora Enrique N	EVP & CFO	Jan 15 '25	Sale	81.43	5,000	407,150	20,260	Jan 17 04:41 PM
Livesay Jill A	VP, Controller & PAO	Jan 15 '25	Option Exercise	63.04	13,009	820,087	22,457	Jan 17 04:41 PM
Livesay Jill A	VP, Controller & PAO	Jan 15 '25	Sale	81.00	13,009	1,053,729	9,448	Jan 17 04:41 PM
Mayor-Mora Enrique N	Officer	Jan 15 '25	Proposed Sale	81.43	5,000	407,133		Jan 15 03:15 PM
Shamim Mohammad	EVP and CITO	Jan 08 '25	Option Exercise	63.04	12,845	809,749	24,583	Jan 10 04:42 PM
Shamim Mohammad	EVP and CITO	Jan 08 '25	Sale	81.94	12,845	1,052,519	11,738	Jan 10 04:42 PM
Shamim Mohammad	Officer	Jan 08 '25	Proposed Sale	81.94	12,845	1,052,472		Jan 08 04:37 PM
Lyski James	EVP, Chief Growth & Strat Off	Jan 02 '25	Option Exercise	63.04	57,986	3,655,437	80,789	Jan 03 04:13 PM
Lyski James	EVP, Chief Growth & Strat Off	Jan 02 '25	Sale	81.35	57,986	4,717,161	22,803	Jan 03 04:13 PM
Lyski James	Officer	Jan 02 '25	Proposed Sale	81.35	57,986	4,717,412		Jan 02 05:23 PM
Daniels Jon G	SVP, CAF	Dec 26 '24	Option Exercise	63.04	10,000	630,400	10,995	Dec 27 04:13 PM
Daniels Jon G	SVP, CAF	Dec 26 '24	Sale	85.30	10,000	853,000	995	Dec 27 04:13 PM
Shamim Mohammad	EVP and CITO	Dec 23 '24	Option Exercise	63.04	10,000	630,400	21,738	Dec 26 04:15 PM
Shamim Mohammad	EVP and CITO	Dec 23 '24	Sale	83.77	10,000	837,700	11,738	Dec 26 04:15 PM
Nash William D	President & CEO	Dec 23 '24	Option Exercise	63.04	120,513	7,597,140	302,196	Dec 26 04:15 PM
Nash William D	President & CEO	Dec 23 '24	Sale	83.24	120,513	10,030,953	181,683	Dec 26 04:15 PM
Daniels Jon G	SVP, CAF	Dec 24 '24	Option Exercise	63.04	30,245	1,906,645	31,240	Dec 26 04:15 PM
Daniels Jon G	SVP, CAF	Dec 23 '24	Option Exercise	63.04	7,600	479,104	8,595	Dec 26 04:15 PM
Daniels Jon G	SVP, CAF	Dec 24 '24	Sale	84.34	30,245	2,550,863	995	Dec 26 04:15 PM
Daniels Jon G	SVP, CAF	Dec 23 '24	Sale	84.00	7,600	638,400	995	Dec 26 04:15 PM
Daniels Jon G	Officer	Dec 26 '24	Proposed Sale	85.30	10,000	853,039		Dec 26 04:07 PM
Daniels Jon G	Officer	Dec 24 '24	Proposed Sale	85.00	15,000	1,275,000		Dec 26 12:22 PM
Daniels Jon G	Officer	Dec 23 '24	Proposed Sale	84.00	22,845	1,918,980		Dec 23 04:50 PM
Shamim Mohammad	Officer	Dec 23 '24	Proposed Sale	86.69	22,845	1,980,360		Dec 23 04:38 PM
Nash William D	Officer	Dec 23 '24	Proposed Sale	82.00	120,513	9,882,066		Dec 23 04:28 PM

PFE

Pfizer Inc

KMX

Carmax Inc

Upgrade your FINVIZ experience